Results 171 to 180 of about 12,194 (220)

Autocatalytic Reaction between HCN and Cysteamine Produces Hydrophobic, Catalytic, Liquid Compartments. [PDF]

J Am Chem Soc
Novichkov AI, Diskin-Posner Y, Shimon LJW, Leitus G, Flamm C, Semenov SN.   +5 more
europepmc   +1 more source

Stimulus-Responsive Perselenide, Thioselenide, and Selenosulfide Donors for Reactive Selenium Species Chemical Biology. [PDF]

J Am Chem Soc
Tripathi R, Hankins RA, Yi J, Liu L, Presti RS, Cohen MH, Sawase LR, Luna TD, Ding W, Lukesh JC.   +9 more
europepmc   +1 more source

Innovations in Refractory Melasma: Mechanism-Based Management and Emerging Therapeutic Strategies. [PDF]

Cureus
Laguna Rocafort S, Rivera-Díaz J, Bonilla IM, Rabelo-Cartagena J.   +3 more
europepmc   +1 more source

CystamineとCysteamine

VITAMINS, 1953
openaire   +1 more source

Cysteamine Toxicity in Patients with Cystinosis

The Journal of Pediatrics, 2011
To report new adverse effects of cysteamine.Detailed clinical information was obtained from the patients' physicians.New adverse events were reported in 8 of 550 patients with cystinosis treated with cysteamine in Europe during the last 5 years. Detailed clinical information was not available for 2 of these patients, 1 of whom died from cerebral ...
Besouw, M.T., Bowker, R., Dutertre, J.P., Emma, F., Gahl, W.A., Greco, M., Lilien, M.R., McKiernan, J., Nobili, F., Schneider, J.A., Skovby, F., van den Heuvel, L.P., van den Heuvel, L.P., van 't Hoff, W.G., Levtchenko, E.N.   +14 more
openaire   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Cysteamine and cystamine

1987
Publisher Summary This chapter discusses about cysteamine and cystamine. Cysteamine (2-aminoethanethiol) is formed in mammalian tissues by the enzymatic hydrolysis of pantetheine, and has the role in the biosynthesis of hypotaurine. Cysteamine has been used therapeutically to treat cystinosis and sickle cell anemia, and has been used as a protective ...
M W, Duffel, D J, Logan, D M, Ziegler
openaire   +2 more sources

Treatment of cystinosis with cysteamine

The Journal of Pediatrics, 1979
C v s T I N 0 S I S is a recessively inherited metabolic disorder characterized by an accumulation of nonprotein cystine within the lysosomes. 1 ! n the juvenile nephropathic form, the disease presents with tubular renal dysfunction and progressive glomerular damage, leading to end-stage renal failure and eventual death.
E P, Girardin, M S, DeWolfe, J F, Crocker   +2 more
openaire   +2 more sources

Metal Content of Cysteamine Oxygenase

European Journal of Biochemistry, 1968
Cysteamine oxygenase has been analysed for the presence of metals, by spectrographic analysis, and X‐ray fluorescence. Iron, copper, and zinc have been found in the enzyme in the quantity accounting for 1 atom of each metal per molecule of enzyme.Passage of the enzyme through a chelating resin column did not appreciable change the specific activity but
D, Cavallini, S, Duprè, R, Scandurra, M T, Graziani, F, Cotta-Rasusino   +4 more
openaire   +2 more sources

Cysteamine

Drug Discovery Today, 2013
Cysteamine is an amino thiol with the chemical formula HSCH2CH2NH2. Endogenously, cysteamine is derived from coenzyme A degradation, although its plasma concentrations are low. Most experience with cysteamine as a drug originates from the field of the orphan disease cystinosis, in which cysteamine is prescribed to decrease intralysosomal cystine ...
Besouw, Martine, Masereeuw, R., van den Heuvel, Lambert, Levtchenko, Elena   +3 more
openaire   +2 more sources

Adrenergic blocking action of cysteamine

Experientia, 1962
Il a ete demontre que la cysteamine provoque une activation centrale adrenergique accompagnee par une liberation des catecholamines de la surrenale. Plus tard cet effet est suivi par un blocage periferique des recepteurs adrenergiques.
R, DEBIJADJI, V, VARAGIC, S, ELCIC, J, DAVIDOVIC   +3 more
openaire   +2 more sources